Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
James Olson
Fred Hutchinson Cancer Research Center, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Blaze Biosciences
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Blaze has an option to license the molecule that will be studied in this grant. The value of Dr. Olson’s financial interests in Blaze could therefore be impacted depending on the outcome of this research.
Engineering knotted peptide therapeutics for pediatric brain tumor patients
Brain tumors cause more deaths in children than any other form of cancer. Building on our success in advancing Tumor Paint to clinical trials to help surgeons remove pediatric brain cancers, we now propose to understand the mechanism by which Tumor Paint crosses into the brain so that we can engineer therapeutic candidates for children with brain tumors. Toward maximizing benefit to childhood brain cancer survivors, we propose to use information about Tumor Paint to help engineer a drug candidate that would prevent brain damage caused by radiation therapy in these children.
Filed on January 18, 2018.
Tell us what you know about James Olson's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
James Olson filed other conflict of interest disclosures with the NIH:
Name | Institution | Type | Company | Disclosed Value |
---|---|---|---|---|
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Presage Biosciences | $100,000 - $149,999 |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Presage Biosciences | $80,000 - $99,999 |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Presage Biosciences | $80,000 - $99,999 |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Blaze Biosciences | $40,000 - $59,999 |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Presage Biosciences | $40,000 - $59,999 |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Blaze Biosciences | $40,000 - $59,999 |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Presage Biosciences | Value cannot be readily determined |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Presage Biosciences | Value cannot be readily determined |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Blaze Biosciences | Value cannot be readily determined |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Presage Biosciences | Value cannot be readily determined |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Presage Biosciences | Value cannot be readily determined |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Blaze Biosciences | Value cannot be readily determined |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Presage Biosciences | Value cannot be readily determined |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Presage Biosciences | Value cannot be readily determined |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Presage Biosciences | Value cannot be readily determined |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Presage Biosciences | Value cannot be readily determined |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Blaze Biosciences | Value cannot be readily determined |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Presage Biosciences | Value cannot be readily determined |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Presage Biosciences | Value cannot be readily determined |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Presage Biosciences | Value cannot be readily determined |
James Olson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Presage Biosciences | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.